EDOG - Institut Bergonie - PPDS

Bordeaux 33076

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, B-Cell, Small Cell Lung Cancer Extensive Stage, Small Cell Lung Cancer Recurrent, Small Cell Lung Carcinoma, Small-cell Lung Cancer

Studies at this site

• KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer — Stopped early
• Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma — Withdrawn before enrolling